ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,567.30
-0.98%
S&P ASX All Technology
2,930.40
-1.06%
Brent Oil
86.625
0.00%
US Dollar vs AUD
1.5586
0.00%
Bitcoin
63,844.65
0.03%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Avacta Group Plc (AVCT)

  7. Avacta Group Plc (AVCT) News

AVCT Avacta Group Plc

48.50
0.50 (1.04%)
20 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Avacta Group Plc AVCT London Ordinary Share
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.50 1.04% 48.50 01:35:17
Open Price Low Price High Price Close Price Previous Close
47.75 45.75 47.75 48.50 48.00
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Recent News

Date Time Source Heading
10/4/202402:00UK RNSAvacta Group PLC Avacta Reports Data at the AACR Annual..
08/4/202416:00UK RNSAvacta Group PLC AVA6000 Abstract Release by AACR
06/4/202407:30UKREGAvacta Group - AVA6000 Abstract Release by AACR and Full..
06/4/202407:30GLOBEAvacta Group - AVA6000 Abstract Release by AACR and Full..
29/3/202403:00UK RNSAvacta Group PLC Investor Webinar
21/3/202421:37ALNCNewsAvacta doses third patient in drug conjugate trial for..
21/3/202418:00UK RNSAvacta Group PLC Update on AVA6000 Phase 1a Clinical Trial..
19/3/202401:31ALNCNewsIN BRIEF: Avacta shareholders give AGM go-ahead to issue new..
19/3/202400:26UK RNSAvacta Group PLC Result of General Meeting
06/3/202418:00UK RNSAvacta Group PLC Avacta Announces AVA6000 Poster at AACR
06/3/202408:30UKREGUpdated Results from Single-Agent Phase 1 Clinical Trial of..
06/3/202404:09ALNCNewsEARNINGS AND TRADING: Harland & Wolff wins major Falklands..
05/3/202418:00UK RNSAvacta Group PLC Result of REX Retail Offer
29/2/202423:18ALNCNewsAvacta increases placing size to GBP26 million thanks to..
29/2/202418:00UK RNSAvacta Group PLC Result of Placing
29/2/202407:31ALNCNewsTRADING UPDATES: Avacta plans fundraise to fund clinical..
29/2/202403:42UK RNSAvacta Group PLC Proposed REX Retail Offer
29/2/202403:41UK RNSAvacta Group PLC Proposed Fundraise to progress Therapeutics
16/2/202418:00UK RNSAvacta Group PLC Share Incentive Plan/Issue of Equity
22/1/202421:51UKREGAvacta Group PLC Issue of Equity and Total Voting Rights
19/1/202420:11ALNCNewsIN BRIEF: Avacta says new head of R&D Coughlin brings "deep..
19/1/202418:00UKREGAvacta Group PLC Appointment of Christina Coughlin
19/12/202323:00GLOBEAppointment of Chief Business Officer
19/12/202320:57ALNCNewsIN BRIEF: Avacta taps biopharma veteran as Therapeutics..
19/12/202318:00UKREGAvacta Group PLC Appointment of Chief Business Officer
13/12/202323:00GLOBEALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety..
13/12/202322:49ALNCNewsAvacta says study shows cancer treatment AVA6000 working as..
13/12/202318:00UKREGAvacta Group PLC ALS-6000-101 Phase 1a Study Data
04/12/202318:00UKREGAvacta Group PLC Shareholder update to review AVA6000 Phase..
30/11/202320:00GLOBELevicept Appoints Eliot Forster as CEO
27/10/202317:00UKREGAvacta Group PLC Block Listing Six Monthly Return
23/10/202323:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
23/10/202323:30UKREGAvacta Group PLC Issue of Equity and Total Voting Rights
18/10/202323:00UKREGAvacta Group PLC Block Listing Application to AIM
05/10/202317:00GLOBEAvacta to present promising new data from Affimer® and..
05/10/202317:00UKREGAvacta Group PLC Avacta to present at AACR-NCI-EORTC..
29/9/202322:30UKREGAvacta Group PLC Director/PDMR Shareholding
28/9/202320:08ALNCNewsIN BRIEF: Avacta loss widens on cost rise but clinical tests..
28/9/202316:00UKREGAvacta Group PLC Interim Results for the Period Ending 30..
20/9/202323:37ALNCNewsTRADING UPDATES: Capital inks contract; Lansdowne becomes..
20/9/202323:00UKREGAvacta Group PLC Issue of Equity and Total Voting Rights
20/9/202316:01UKREGAvacta Group PLC Peel Hunt Appointed as Joint Broker
20/9/202316:00UKREGAvacta Group PLC Appointment Dr.Christina Coughlin as a..
19/9/202322:36ALNCNewsAvacta notes "excellent" safety profile for prospective..
19/9/202316:00UKREGAvacta Group PLC Successful Completion of Sixth Dose..
06/9/202316:00UKREGAvacta Group PLC Notice of Results
22/7/202301:00ALNCNewsIN BRIEF: Avacta Group issues 3.8 million shares to make..
22/7/202300:00UKREGAvacta Group PLC Issue of Equity and Total Voting Rights
28/6/202320:00UKREGAvacta Group PLC Result of Annual General Meeting
28/6/202316:00UKREGAvacta Group PLC Annual General Meeting and Shareholder..

Your Recent History

LSE
AVCT
Avacta
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved